Secondly, we apply CTD as an alternative to existing topology-based pathway enrichment methods in the analysis of gene expression perturbations observed in four major breast cancer subtypes (Luminal A, Luminal B, Her2 and Basal-like) from The Cancer Genome Atlas (TCGA) RNA-seq data [4,5]. The gene discussed is ERBB2; the disease is breast cancer.